Cargando…
From Bench to Bed: The Current Genome Editing Therapies for Glaucoma
Glaucoma is a group of optic neuropathies featured by degeneration of retinal ganglion cells and loss of their axons in the optic nerve. The only currently approved therapies focus on lowering intraocular pressure with medication and surgery. Over the previous few decades, technological advances and...
Autores principales: | He, Meihui, Rong, Rong, Ji, Dan, Xia, Xiaobo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149310/ https://www.ncbi.nlm.nih.gov/pubmed/35652098 http://dx.doi.org/10.3389/fcell.2022.879957 |
Ejemplares similares
-
Oncolytic Virotherapy: From Bench to Bedside
por: Yang, Ludi, et al.
Publicado: (2021) -
Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications
por: Salah, Ahmed, et al.
Publicado: (2021) -
CRISPR Toolbox for Genome Editing in Dictyostelium
por: Yamashita, Kensuke, et al.
Publicado: (2021) -
Umbilical cord mesenchymal stromal cells—from bench to bedside
por: Chetty, Shashank, et al.
Publicado: (2022) -
Potential Roles of the Retinoblastoma Protein in Regulating Genome Editing
por: Jiang, Yuning, et al.
Publicado: (2018)